B.Brilliant Revelation Comparision Study

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
University of Pennsylvania
Study ID
NCT07067788
Status
Recruiting
Apply to this trial

Conditions

  • Breast Cancer Screening

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Breast Imaging — DIAGNOSTIC_TEST
    Intervention using an FDA-approved mammogram machine.

Study Details

This is an observational study to evaluate the MAMMOMAT B.brilliant system. All diagnostic decisions are made by the treating radiologist based upon standard of care clinical imaging acquired on FDA approved devices

Key Dates

Start date
Dec 15, 2025
Status verified
Apr 2026
Primary completion
Jul 30, 2026
Completion
Jan 30, 2027

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: Breast imaging in Females
    Females who are equal to or greater than 18 years of age are scheduled to have additional imaging due to findings of calcifications or lesions with calcifications on a screening mammogram.

Primary Outcome Measure

Comparison of two Siemen System B.brillant and the Revelation [ Time Frame: From enrollment to the end of study at 18 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Pennsylvania Hospital, Center for Breast ImagingPhiladelphiaPennsylvania19107
Jessica Nunez
[email protected]
215-829-3712
Namaijah Faison, MPH
[email protected]
267-432-5000
Brian S. Englander, MD (PRINCIPAL_INVESTIGATOR)
Elizabeth McDonald, MD, PHD (SUB_INVESTIGATOR)

Find similar trials in Philadelphia, PA

By research site
Pennsylvania Hospital, Center for Breast Imaging· Philadelphia, PA

Related Studies